Please assess the completion status of the following clinical trial:

Trial Title: Azithromycin for Child Survival in Niger: Programmatic Trial (AVENIR)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Intervention~At the community-level, eligibility includes:~Inclusion Criteria:~* Location in Dosso, Tahoua, Maradi, Zinder, or Tillabéri regions~* Distinguishable from neighboring communities~* Verbal consent of community leader(s)~Exclusion criteria:~* Inaccessible or unsafe for study team~* Quartier designation on national census~At the individual-level, eligibility includes:~Inclusion criteria:~* Age 1-11 months~* Primary residence in a study community~* Verbal consent of caregiver/guardian for study participation~Exclusion criteria:~* Known allergy to macrolides~Population-based sample collections~At the community-level, eligibility includes:~Inclusion criteria:~* Location in study region~* Distinguishable from neighboring communities~* Verbal consent of community leader(s)~Exclusion criteria:~* Inaccessible or unsafe for study team~* Included in MORDOR trials~* Not randomly selected~At the individual-level, eligibility includes:~Inclusion criteria:~* Age 1-59 months or 7-12 years or caregiver/guardian of a child eligible for treatment~* Primary residence in a study community selected for sample collections~* Verbal consent of caregiver/guardian for study participation~Exclusion criteria:~* Not on list of randomly selected participants from the census

- Gender: ALL
- Minimum Age: 1 Month
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Programmatic azithro 1-11 (Type: ACTIVE_COMPARATOR): Biannual oral azithromycin administration to children aged 1-11 months distributed by community health workers
- no intervention (Type: NO_INTERVENTION): No additional intervention.

Based on this trial design, predict the completion outcome and termination type (if applicable).